DisperSol Technologies Garners $10,000,000 New Round

  • Feed Type
  • Date
    2/3/2015
  • Company Name
    DisperSol Technologies
  • Mailing Address
    111 W. Cooperative Way Georgetown, TX 78626 USA
  • Company Description
    Many potentially effective drugs that have been discovered have either failed completely to be turned into patient viable medicines or become only partially effective medicines because of drug solubility or manufacturing processing limitations. At DisperSol, our mission is to use our proprietary KinetiSol technology to make new and better medicines with these drugs to help patients.
  • Website
    http://www.dispersoltech.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $10,000,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    The company will use the funds to expand its drug formulation and GMP manufacturing.
  • M&A Terms
  • Venture Investor
  • Venture Investor

Trending on Xconomy